Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease

NCT02760368 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

428

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Olokizumab
DRUG: Placebo

Sponsor

R-Pharm International, LLC

Collaborators

[object Object]
[object Object]
[object Object]